Janux Therapeutics
JANX
$64.78
Share price
3.76%
Change (1 day)
331.87%
Change (1 year)
Categories
P/S ratio for Janux Therapeutics (JANX)
P/S ratio as of May 2024 (TTM): 400
According to Janux Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 400.475. At the end of 2023 the company had a P/S ratio of 61.3.
P/S ratio history for Janux Therapeutics from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 61.3 | -3.81% |
| 2022 | 63.7 | -71.77% |
| 2021 | 226 |